agilon health, inc.
AGL
$0.73
$0.045.11%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.22% | 11.79% | 23.09% | 40.40% | 54.06% |
| Total Other Revenue | -1.11% | 0.37% | 14.39% | 42.18% | 75.07% |
| Total Revenue | 5.21% | 11.76% | 23.07% | 40.41% | 54.10% |
| Cost of Revenue | 6.15% | 14.81% | 25.31% | 42.60% | 63.34% |
| Gross Profit | -107.85% | -311.49% | -127.26% | -93.05% | -129.82% |
| SG&A Expenses | -13.19% | -13.00% | -11.81% | -7.44% | -5.55% |
| Depreciation & Amortization | 23.85% | 30.86% | 34.66% | 52.48% | 118.48% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.34% | 13.46% | 23.24% | 39.49% | 58.26% |
| Operating Income | -7.49% | -49.19% | -26.74% | -22.42% | -182.30% |
| Income Before Tax | -3.27% | -52.54% | -27.11% | -27.96% | -353.96% |
| Income Tax Expenses | 4,417.95% | -19.08% | -26.35% | 83.44% | -103.56% |
| Earnings from Continuing Operations | -3.83% | -51.95% | -26.47% | -28.18% | -346.76% |
| Earnings from Discontinued Operations | 119.83% | 116.40% | 116.24% | 85.46% | -283.24% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -100.00% | -100.00% | -117.54% | -124.15% | -99.58% |
| Net Income | 19.89% | -5.71% | 15.00% | 0.93% | -334.16% |
| EBIT | -7.49% | -49.19% | -26.74% | -22.42% | -182.30% |
| EBITDA | -6.34% | -50.82% | -25.35% | -20.19% | -188.26% |
| EPS Basic | 20.87% | -4.31% | 16.03% | 2.24% | -333.15% |
| Normalized Basic EPS | -1.07% | -50.34% | -24.04% | -22.45% | -349.86% |
| EPS Diluted | 20.80% | -3.55% | 16.76% | 3.89% | -311.61% |
| Normalized Diluted EPS | -1.07% | -50.34% | -24.04% | -22.29% | -348.13% |
| Average Basic Shares Outstanding | 0.92% | 1.10% | 1.00% | 0.50% | 0.05% |
| Average Diluted Shares Outstanding | 0.92% | 1.10% | 1.00% | -0.32% | -0.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |